ϳԹ

Skip to main content

Case Comprehensive Cancer Center

ACG%20Cup%20Competition%20202%20First%20Place%20Team_0.jpg
Hero Type
Image
Barnholtz-Sloan elected Representative, Society for Neuro-Oncology Board of Directors
The Case Comprehensive Cancer Center extends congratulations to Jill Barnholtz-Sloan, PhD as she was recently elected as a representative to the board of the Society for Neuro-Oncology. Dr. Barnholtz-Sloan is the Sally S. Morley Designated Professor in Brain Tumo...
Forefront_Summer2023_SideBySide.jpg
Hero Type
Image
Karathanasis, Schiemann lead team fighting breast cancer with nanotechnology and immunotherapy
Efstathios "Stathis” Karathanasis, PhD and William Schiemann, PhD are leading a team of researchers from the Case Comprehensive Cancer Center (Case CCC) and Duke University combining nanotechnology with immunotherapy to treat metastatic breast cancer. The team received a five-year, $3M grant from th...
Eng receives new grant to investigate genomic alterations influencing PTEN hamartoma tumor syndrome
Charis Eng, MD, PhD, received a two-year, nearly $680,000 grant from the PTEN Research Foundation to investigate how genomic alterations influence PTEN hamartoma tumor syndrome (PHTS). With this grant, Dr. Eng’s team will sequence the whole genomes of a large number of PHTS patients from around the ...
221011_Camille_Warner_3_INTERNET%20copy.jpg
Hero Type
Image
NIH funds Case Comprehensive Cancer Center research into differences in glioblastoma between males and females
A Case Comprehensive Cancer-led team has secured $10.4 million over five years from the National Institutes of Health/National Cancer Institute to explore at the molecular level the differences in glioblastoma between males and females. The researchers will delve into the genetics, epigenetics and ...
T-cells
Hero Type
Image
Fighting breast cancer with nanotech, immunotherapy 
ϳԹ researcher takes aim at hard-to-treat metastatic cancers by using new method to unlock ‘cold tumors’ for successful treatment A team of scientists led by aresearcher at the ϳԹ School of Medicine is making strides to fight deadly metastati...
HEC-at-Night.jpg
Hero Type
Image
Calculating alternative interventions for cancer and infection with quantum physics concepts
A team co-led by Cleveland Clinic radiation oncologist Jacob Scott, MD, DPhil and ϳԹ theoretical biophysicist Michael Hinczewski, PhD recently published findings from a new study that demonstrates, for the first time, how quantum physics concepts can assist in the develo...
Chase%20Sloan%20cakes%20for%20cancer.jpeg
Hero Type
Image
Cakes for Cancer: high school student creates cookbook to raise money for research
Chase Sloan, a 15-year-old sophomore at Hawken School and aspiring surgical oncologist, has always enjoyed cooking and baking. He hoped to one day create a cookbook, but that goal seemed far off until early March when the world was forced to essentially shut down due to the COVID-19 pandemic. It was...
t-updatedRayMuzic.jpg
Hero Type
Image
Muzic appointed Director, Radiation Resources Shared Resource
Raymond F. Muzic, Jr, PhD has been appointed director of the Radiation Resources Shared Resource. Dr. Muzic is well suited to oversee the operations of the facility. He has a track record of collaborative, translational research with physicians from many departments and especially in Nuclear Medicin...
Cancer
Hero Type
Image
Mosaic ImmunoEngineering Inc. signs license-option to advance novel immunotherapy to treat cancer and infectious diseases
Agreement with ϳԹ Technology Transfer Office and Dartmouth College Mosaic ImmunoEngineering Inc., a private biotechnology company based in Novato, California, has signed a two-year option agreement with ϳԹ and Dartmouth College, granting the company the exclusive righ...
ACIHM%203.jpg
Hero Type
Image
Jung named chair of cancer biology at Cleveland Clinic Lerner Research Institute
Jae Jung, PhD has been appointed chair of Lerner Research Institute's Department of Cancer Biology where he will lead the department’s work in understanding the biological underpinnings of cancer ranging from genetic and molecular pathways to disease manifestation. ...